NPPA issued a notification regarding the fixation of retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (as film coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg+ Aspirin IP 75mg (As Gastro-resistant tablet) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Pvt. Ltd. (Marketer)

Mar 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 17, 2026, issued a notification regarding the fixation of retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (as film coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg+ Aspirin IP 75mg (As Gastro-resistant tablet) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Pvt. Ltd. (Marketer).

The following has been stated: -

• Each hard gelatin capsule contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (as film-coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg + Aspirin IP 75mg (As Gastro-resistant tablet) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Pvt. Ltd. (Marketer), the retail price is 6.19 (Rs).

[Notification No.: 19(5047)/2026/DP/NPPA/Div.III/13395/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT